Black Rock Inc. Inovio Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.35 - $0.53 $695,303 - $1.05 Million	-1,986,582 Reduced 33.56%	3,932,564 $2.01 Million
Q3 2023 Nov 13, 2023	SELL	$0.38 - $0.58 $63,641 - $97,136	-167,477 Reduced 2.75%	5,919,146 $2.31 Million
Q2 2023 Aug 11, 2023	SELL	$0.39 - $0.94 $6.68 Million - $16.1 Million	-17,134,235 Reduced 73.79%	6,086,623 $2.74 Million
Q1 2023 May 12, 2023	SELL	$0.79 - $1.91 $49,976 - $120,828	-63,261 Reduced 0.27%	23,220,858 $19 Million
Q4 2022 Feb 13, 2023	BUY	$1.41 - $2.5 $2.45 Million - $4.35 Million	1,739,409 Added 8.07%	23,284,119 $36.3 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $2.69 Million - $4.52 Million	1,619,104 Added 8.13%	21,544,710 $37.2 Million
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $2.71 Million - $7.48 Million	1,878,705 Added 10.41%	19,925,606 $34.5 Million
Q1 2022 May 12, 2022	SELL	$2.97 - $5.2 $588,098 - $1.03 Million	-198,013 Reduced 1.09%	18,046,901 $64.8 Million
Q4 2021 Feb 10, 2022	SELL	$4.99 - $7.46 $622,447 - $930,552	-124,739 Reduced 0.68%	18,244,914 $91 Million
Q3 2021 Nov 09, 2021	BUY	$7.16 - $9.69 $1.42 Million - $1.92 Million	197,952 Added 1.09%	18,369,653 $132 Million
Q2 2021 Aug 11, 2021	BUY	$6.23 - $10.03 $113 Million - $182 Million	18,171,701 New	18,171,701 $168 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $456M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.